(1) BENEFICIARY.
The term beneficiary means an individual who is
entitled to benefits under part A and enrolled under part B, including
any individual who is enrolled in a Medicare Advantage plan under
part C.
(2) HEALTH CARE GROUP.
(A)
IN GENERAL. The term health care group means
(i)
a group of physicians that is organized at least in part for the
purpose of providing physicians services under this title;
(ii) an integrated health care delivery system that delivers care
through coordinated hospitals, clinics, home health agencies,
ambulatory surgery centers, skilled nursing facilities, rehabilitation
facilities and clinics, and employed, independent, or contracted
physicians; or
(iii) an organization representing regional coalitions of groups
or systems described in clause (i) or (ii).
(B)
INCLUSION. As the Secretary determines appropriate, a health
care group may include a hospital or any other individual or entity
furnishing items or services for which payment may be made under
this title that is affiliated with the health care group under an
arrangement structured so that such hospital, individual, or entity
participates in a demonstration project under this section.
(3) PHYSICIAN.
Except as otherwise provided for by the Secretary, the term
physician means any individual who furnishes services
that may be paid for as physicians services under this title.
(b) DEMONSTRATION
PROJECTS. The Secretary shall establish a 5-year demonstration
program under which the Secretary shall approve demonstration projects
that examine health delivery factors that encourage the delivery of
improved quality in patient care, including
(1) the
provision of incentives to improve the safety of care provided to
beneficiaries;
(2) the appropriate use of best practice guidelines by providers and
services by beneficiaries;
(3) reduced scientific uncertainty in the delivery of care through
the examination of variations in the utilization and allocation of
services, and outcomes measurement and research;
(4) encourage shared decision making between providers and patients;
(5) the provision of incentives for improving the quality and safety
of care and achieving the efficient allocation of resources;
(6) the appropriate use of culturally and ethnically sensitive health
care delivery; and the financial effects on the health care marketplace
of altering the incentives for care delivery and changing the allocation
of resources.
(c) ADMINISTRATION
BY CONTRACT.
(1) IN
GENERAL. Except as otherwise provided in this section, the
Secretary may administer the demonstration program established under
this section in a manner that is similar to the manner in which the
demonstration program established under section 1866A is administered
in accordance with section 1866B.
(2) ALTERNATIVE PAYMENT SYSTEMS. A health care group that receives
assistance under this section may, with respect to the demonstration
project to be carried out with such assistance, include proposals
for the use of alternative payment systems for items and services
provided to beneficiaries by the group that are designed to
(A)
encourage the delivery of high quality care while accomplishing
the objectives described in subsection (b); and
(B) streamline documentation and reporting requirements otherwise
required under this title.
(3) BENEFITS.
A health care group that receives assistance under this section
may, with respect to the demonstration project to be carried out with
such assistance, include modifications to the package of benefits
available under the original Medicare fee-for-service program under
parts A and B or the package of benefits available through a Medicare
Advantage plan under part C. The criteria employed under the demonstration
program under this section to evaluate outcomes and determine best
practice guidelines and incentives shall not be used as a basis for
the denial of Medicare benefits under the demonstration program to
patients against their wishes (or if the patient is incompetent, against
the wishes of the patients surrogate) on the basis of the patients
age or expected length of life or of the patients present or
predicted disability, degree of medical dependency, or quality of
life.
(d) ELIGIBILITY
CRITERIA. To be eligible to receive assistance under this section,
an entity shall
(1) be
a health care group;
(2) meet quality standards established by the Secretary, including
(A)
the implementation of continuous quality improvement mechanisms
that are aimed at integrating community-based support services,
primary care, and referral care;
(B) the implementation of activities to increase the delivery of
effective care to beneficiaries;
(C) encouraging patient participation in preference-based decisions;
(D) the implementation of activities to encourage the coordination
and integration of medical service delivery; and
(E) the implementation of activities to measure and document the
financial impact on the health care market-place of altering the
incentives of health care delivery and changing the allocation of
resources; and
(3) meet
such other requirements as the Secretary may establish.
(e) WAIVER
AUTHORITY. The Secretary may waive such requirements of titles
XI and XVIII as may be necessary to carry out the purposes of the demonstration
program established under this section.
(f) BUDGET
NEUTRALITY. With respect to the 5-year period of the demonstration
program under subsection (b), the aggregate expenditures under this
title for such period shall not exceed the aggregate expenditures that
would have been expended under this title if the program established
under this section had not been implemented.
(g) NOTICE
REQUIREMENTS. In the case of an individual that receives health
care items or services under a demonstration program carried out under
this section, the Secretary shall ensure that such individual is notified
of any waivers of coverage or payment rules that are applicable to such
individual under this title as a result of the participation of the
individual in such program.
(h) PARTICIPATION
AND SUPPORT BY FEDERAL AGENCIES. In carrying out the demonstration
program under this section, the Secretary may direct
(1) the
Director of the National Institutes of Health to expand the efforts
of the Institutes to evaluate current medical technologies and improve
the foundation for evidence-based practice;
(2) the Administrator of the Agency for Healthcare Research and Quality
to, where possible and appropriate, use the program under this section
as a laboratory for the study of quality improvement strategies and
to evaluate, monitor, and disseminate information relevant to such
program; and
(3) the Administrator of the Centers for Medicare & Medicaid Services
and the Administrator of the Center for Medicare Choices to support
linkages of relevant Medicare data to registry information from participating
health care groups for the beneficiary populations served by the participating
groups, for analysis supporting the purposes of the demonstration
program, consistent with the applicable provisions of the Health Insurance
Portability and Accountability Act of 1996.